Physician profile
Lysa A Long
NPI 1619110418
$978.24
in general payments reported to CMS, 2019-2025
18 companies · $279 in 2025
The $279 reported for 2025 was more than what 88% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.32 · 2022: $354 · 2023: $147 · 2024: $183 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $159.21 | 2022 | |
| Hologic Sales and Service, LLC | $157.93 | 2022-2025 | Aptima |
| Abbvie INC. | $147.34 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $107.73 | 2023-2025 | |
| Organon LLC | $68.59 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $55.78 | 2023-2024 | Veozah |
| Novo Nordisk INC | $39.70 | 2024-2025 | Wegovy |
| Sage Therapeutics, LLC | $38.61 | 2023-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $35.21 | 2022 | |
| Mylan Pharmaceuticals INC. | $28.74 | 2021-2022 | |
| Daiichi Sankyo INC. | $21.50 | 2023 | Injectafer |
| Coopersurgical, INC. | $20.64 | 2025 | Paragard T 380a |
| Pfizer INC. | $19.19 | 2025 | |
| Lilly USA, LLC | $18.62 | 2024 | Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $15.48 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $14.88 | 2023 | Accrufer |
| Exeltis, USA INC. | $14.58 | 2024 | Slynd |
| Therapeuticsmd, INC. | $14.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lysa Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.